Modeling Genetic Epilepsies with Induced Pluripotent Stem Cells
Dr. Andrew Tidball’s work in the Parent lab involves modeling severe genetic epilepsies in neurons from patient-derived induced pluripotent stem (iPS) cells. He uses gene-editing techniques to generate isogenic controls and “virtual” patient iPS cell lines that he differentiates into neurons for functional analysis. In this webinar, Dr. Tidball discusses current and potential uses of iPS cells for modeling epilepsies, how to develop different iPS cell-based model systems, as well as the key advantages and drawbacks of using these model systems.
Publish Date:
June 01, 2017
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
Neuronal Phenotyping of an iPS Cell Model of Rett Syndrome
Publish Date: May 04, 2015 -
The Road to Functional Human Neuronal Circuits in Vitro
Publish Date: May 03, 2016
